| Literature DB >> 23941600 |
Yan Lin1, Changjun Wang, Ying Zhong, Xin Huang, Li Peng, Guangliang Shan, Ke Wang, Qiang Sun.
Abstract
PURPOSE: The association between striking life events, an important stress and acute anxiety disorder, and the occurrence of primary breast cancer is unclear. The current meta-analysis was designed to assess the relationship between striking life events and primary breast cancer incidence in women.Entities:
Mesh:
Year: 2013 PMID: 23941600 PMCID: PMC3751759 DOI: 10.1186/1756-9966-32-53
Source DB: PubMed Journal: J Exp Clin Cancer Res ISSN: 0392-9078
Characteristics and downs &black scores of studies included in the meta-analysis
| Chen 1995 [ | England | Case–control | 4 point scale (great, moderate, some, and little or no) | 41/78 | 20 – 70 | Great life events | None | No description | All stages | No description | 7.08 (2.31-21.65) | 18 |
| Roberts 1996 [ | America | Case–control | Holmes-Rahe life-event weights | 258/614 | 50 - 79 | Stressful life events | Allow for both shorter time of administration and appropriateness (primarily older women) | During the previous 5 years | All stages | Hormone replacement therapy | 0.9 (0.78-1.05) | 18 |
| Protheroe 1999 [ | Australia | Case–control | Four point scale, and six point scale for severity difficulties lasting 4 weeks | 106/226 | 40 - 79 | Stressful life events | Excluded events that were related to past and present breast problems, or a first degree relative's breast cancer | During the previous 5 years | All stages | Hormone replacement therapy | 0.91 (0.47-1.81) | 17 |
| Oral contraceptives | ||||||||||||
| Kruk 2012 [ | Poland | Case–control | Holmes-Rahe life-event weights | 858/1085 | 28 - 79 | Life events | The association between job stress and breast cancer was determined in separate analysis | During the previous 3 years | All stages | Hormone replacement therapy | 5.09 (3.41-8.50) | 18 |
| Helgesson 2003 [ | Sweden | Prospective | 1–6 on the stress scale | 1462 | 38 - 60 | Stressful events | None | During the previous 5 years | All stages | No description | 2.1 (1.2-3.7) | 20 |
| Lillberg 2003 [ | Finland | Prospective | Holmes-Rahe life-event weights | 10808 | >24 | Stressful life events | None | During the previous 5 years | All stages | Oral contraceptives | 1.07 (1.00-1.15) | 20 |
| Michael 2009 [ | America | Prospective | Number of life events and amount of upset | 84334 | 50 - 79 | Life events | None | During the previous 1 years | All stages | No description | 1.12 (1.01-1.25) | 19 |
RR relative risk, CI confidence interval.
Figure 1Meta-analysis of the relative risk, or odds ratio, for the association between striking life events and primary breast cancer incidence. Solid squares represent risk estimates for the individual studies, with the size of the squares proportional to the sample size and the number of events. Horizontal lines denote 95% confidence intervals (CIs). The diamond shows the confidence interval for the pooled relative risks. Positive values indicate an increased relative risk for primary breast cancer development. Test for overall effect: Z = 2.99, P < 0.01; chi-square test for heterogeneity = 80.53, degrees of freedom = 6, P < 0.001; I2 = 93%.
Characteristics and downs &black scores of studies assessing serious striking life events
| Chen 1995 [ | England | Case–control | Severe life events | 11.64 (3.10-43.66) |
| Protheroe 1999 [ | Australia | Case–control | Severe life events | 0.91 (0.47-1.81) |
| Kruk 2012 [ | Poland | Case–control | Major life events | 5.33 (4.01-8.21) |
| Helgesson 2003 [ | Sweden | Prospective | Stressful events | 2.1 (1.2-3.7) |
| Lillberg 2003 [ | Finland | Prospective | Major life events | 1.35 (1.09-1.67) |
| Michael2009 [ | America | Prospective | ≥4 life events | 0.91 (0.77-1.08) |
RR relative risk, CI confidence interval.
Figure 2Meta-analysis of the relative risk, or odds ratio, for the association between severe striking life events and primary breast cancer incidence. Solid squares represent risk estimates for the individual studies. The size of the squares is proportional to the sample size and the number of events. The horizontal lines denote 95% confidence intervals (CIs). The diamond shows the confidence interval for the pooled relative risks. Positive values indicate an increased relative risk for primary breast cancer incidence. Test for overall effect: Z = 2.23, P < 0.01; chi-square test for heterogeneity = 123.79, degrees of freedom = 5, P < 0.001; I2 = 96%.